MARIANO ESTEBAN

Profesor

Centro Nacional de Biotecnología

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

LinkedIn

Google Scholar

About

Mariano Esteban is a Professor at the Centro Nacional de Biotecnología in Spain. His research focuses on immunology, particularly in the development of vaccines against viral infections such as SARS-CoV-2 and Zika virus. Recent articles authored by him highlight the role of ISG15 in immune response modulation and the efficacy of various vaccine candidates in inducing protective immunity.

Articles (14)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2

Year:

2025

B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2

Year:

2024

Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers

Year:

2024

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

Year:

2023

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses

Year:

2023

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

Year:

2023

Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens

Year:

2023

Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.

Year:

2022

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy

Year:

2022

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection

Year:

2022

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

Year:

2022

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2

Year:

2022

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara

Year:

2022

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice

Year:

2022

Collaborators (11)

Alexy Inciarte

Associated profesor

University of Barcelona

SPAIN

Andreas Meyerhans

ICREA Research Professor

Instituciò Catalana de Recerca i Estudis Avancats

SPAIN

Karine Breckpot

Professor

Vrije Universiteit Brussel

BELGIUM

Lorenzo Franceschini

Vrije Universiteit Brussel

BELGIUM

Daniel Cabello-Rivera

Lecturer

Fundación Universitaria San Pablo CEU

SPAIN

Raphael Gottardo

University of Lausanne

SWITZERLAND

Juan José Lasarte

Universidad de Navarra

SPAIN

Arthur Esprit

Vrije Universiteit Brussel

BELGIUM

Ana Blazquez

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA-CSIC) Madrid, ES

SPAIN

Alberto Pascual

-

SPAIN

Francisco Javier Villadiego Luque

Associate Professor

Universidad de Sevilla

SPAIN

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI